Corrigendum to "Effects of a single dose of N-carbamylglutamate on the rate of ureagenesis" [Mol. Genet. Metab. 98 (2009) 325-330] (DOI:10.1016/j.ymgme.2009.07.010);Effects of a single dose of N-carbamylglutamate on the rate of ureagenesis

Molecular Genetics and Metabolism

Volumn 98, Issue 4, 2009, Pages 325-330

  Mew, Nicholas Ah ^a   Payan, Irma ^b   Daikhin, Yevgeny ^b   Nissim, Ilana ^b   Nissim, Itzhak ^b   Tuchman, Mendel ^a   Yudkoff, Marc ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Carbamyl phosphate synthetase; N Acetyl l glutamate synthetase; N Carbamyl l glutamate; Stable isotopes; Urea cycle defects

Indexed keywords

ALANINE; AMMONIA; ARGININE; CARBON 13; GLUCOSE; GLUTAMIC ACID DERIVATIVE; GLUTAMINE; ISOLEUCINE; LEUCINE; N CARBAMYLGLUTAMATE; SODIUM HYDROXIDE; UNCLASSIFIED DRUG; UREA; VALINE;

ADULT; AMINO ACID BLOOD LEVEL; AMMONIA BLOOD LEVEL; ARTICLE; DRUG INFUSION; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; UREA BLOOD LEVEL; UREA CYCLE;

EID: 70350620293     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2010.01.005     Document Type: Erratum

References (42)

1. Hall L.M., Metzenberg R.L., and Cohen P.P. Isolation and characterization of a naturally occurring cofactor of carbamyl phosphate biosynthesis. J. Biol. Chem. 230 (1958) 1013-1021
2. Bachmann C., Colombo J.P., and Jaggi K. N-Acetylglutamate synthetase (NAGS) deficiency: diagnosis, clinical observations and treatment. Adv. Exp. Med. Biol. 153 (1982) 39-45
3. Schubiger G., Bachmann C., Barben P., Colombo J.P., Tonz O., and Schupbach D. N-Acetylglutamate synthetase deficiency: diagnosis, management and follow-up of a rare disorder of ammonia detoxication. Eur. J. Pediatr. 150 (1991) 353-356
4. Caldovic L., Morizono H., Panglao M.G., Cheng S.F., Packman S., and Tuchman M. Null mutations in the N-acetylglutamate synthase gene associated with acute neonatal disease and hyperammonemia. Hum. Genet. 112 (2003) 364-368
5. Caldovic L., Morizono H., Panglao M.G., Lopez G.Y., Shi D., Summar M.L., and Tuchman M. Late onset N-acetylglutamate synthase deficiency caused by hypomorphic alleles. Hum. Mutat. 25 (2005) 293-298
6. Grisolia S., and Cohen P.P. The catalytic role of carbamyl glutamate in citrulline biosynthesis. J. Biol. Chem. 198 (1952) 561-571
7. Caldovic L., Morizono H., Daikhin Y., Nissim I., McCarter R.J., Yudkoff M., and Tuchman M. Restoration of ureagenesis in N-acetylglutamate synthase deficiency by N-carbamylglutamate. J. Pediatr. 145 (2004) 552-554
8. Morris A.A., Richmond S.W., Oddie S.J., Pourfarzam M., Worthington V., and Leonard J.V. N-Acetylglutamate synthetase deficiency: favourable experience with carbamylglutamate. J. Inherit. Metab. Dis. 21 (1998) 867-868
9. Guffon N., Vianey-Saban C., Bourgeois J., Rabier D., Colombo J.P., and Guibaud P. A new neonatal case of N-acetylglutamate synthase deficiency treated by carbamylglutamate. J. Inherit. Metab. Dis. 18 (1995) 61-65
10. Hinnie J., Colombo J.P., Wermuth B., and Dryburgh F.J. N-Acetylglutamate synthetase deficiency responding to carbamylglutamate. J. Inherit. Metab. Dis. 20 (1997) 839-840
11. Tuchman M., Caldovic L., Daikhin Y., Horyn O., Nissim I., Korson M., Burton B., and Yudkoff M. N-Carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic acidemia as measured by isotopic incorporation and blood biomarkers. Pediatr. Res. 64 (2008) 213-217
12. Shafai T., Sweetman L., Weyler W., Goodman S.I., Fennessey P.V., and Nyhan W.L. Propionic acidemia with severe hyperammonemia and defective glycine metabolism. J. Pediatr. 92 (1978) 84-86
13. Cathelineau L., Briand P., Ogier H., Charpentier C., Coude F.X., and Saudubray J.M. Occurrence of hyperammonemia in the course of 17 cases of methylmalonic acidemia. J. Pediatr. 99 (1981) 279-280
14. Gebhardt B., Dittrich S., Parbel S., Vlaho S., Matsika O., and Bohles H. N-Carbamylglutamate protects patients with decompensated propionic aciduria from hyperammonaemia. J. Inherit. Metab. Dis. 28 (2005) 241-244
15. Gebhardt B., Vlaho S., Fischer D., Sewell A., and Bohles H. N-Carbamylglutamate enhances ammonia detoxification in a patient with decompensated methylmalonic aciduria. Mol. Genet. Metab. 79 (2003) 303-304
16. Yorifuji T., Muroi J., Uematsu A., Hiramatsu H., and Momoi T. Hyperinsulinism-hyperammonemia syndrome caused by mutant glutamate dehydrogenase accompanied by novel enzyme kinetics. Hum. Genet. 104 (1999) 476-479
17. Stanley C.A. Hyperinsulinism/hyperammonemia syndrome: insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism. Mol. Genet. Metab. 81 Suppl 1 (2004) S45-S51
18. Coude F.X., Rabier D., Cathelineau L., Grimber G., Parvy P., and Kamoun P. A mechanism for valproate-induced hyperammonemia. Adv. Exp. Med. Biol. 153 (1982) 153-161
19. Kim W.H., Park H., Yun C., Cho H., Kim S., Paik W.K., Jeon S.H., and Lee J.H. Mixture of N-carbamoyl-l-glutamate plus l-arginine can protect rats with liver cirrhosis from acute ammonia intoxication. J. Hepatol. 35 (2001) 719-725
20. Cheung C.W., and Raijman L. The regulation of carbamyl phosphate synthetase (ammonia) in rat liver mitochondria. Effects of acetylglutamate concentration and ATP translocation. J. Biol. Chem. 255 (1980) 5051-5057
21. Cohen N.S., Cheung C.W., Kyan F.S., Jones E.E., and Raijman L. Mitochondrial carbamyl phosphate and citrulline synthesis at high matrix acetylglutamate. J. Biol. Chem. 257 (1982) 6898-6907
22. Shigesada K., Aoyagi K., and Tatibana M. Role of acetylglutamate in ureotelism. Variations in acetylglutamate level and its possible significance in control of urea synthesis in mammalian liver. Eur. J. Biochem. 85 (1978) 385-391
23. Meijer A.J., Lof C., Ramos I.C., and Verhoeven A.J. Control of ureogenesis. Eur. J. Biochem. 148 (1985) 189-196
24. Jahoor F., and Wolfe R.R. Reassessment of primed constant-infusion tracer method to measure urea kinetics. Am. J. Physiol. 252 (1987) E557-564
25. Matthews D.E., and Downey R.S. Measurement of urea kinetics in humans: a validation of stable isotope tracer methods. Am. J. Physiol. 246 (1984) E519-527
26. Jones B.N., and Gilligan J.P. O-Phthaldialdehyde precolumn derivatization and reversed-phase high-performance liquid chromatography of polypeptide hydrolysates and physiological fluids. J. Chromatogr. 266 (1983) 471-482
27. Marks V. An improved glucose-oxidase method for determining blood, C.S.F. and urine glucose levels. Clin. Chim. Acta 4 (1959) 395-400
28. el-Khoury A.E., Sanchez M., Fukagawa N.K., Gleason R.E., and Young V.R. Similar 24-h pattern and rate of carbon dioxide production, by indirect calorimetry vs. stable isotope dilution, in healthy adults under standardized metabolic conditions. J. Nutr. 124 (1994) 1615-1627
29. 2H labeled water. Am. J. Clin. Nutr. 33 (1980) 2686-2693
30. Lee B., Yu H., Jahoor F., O'Brien W., Beaudet A.L., and Reeds P. In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle. Proc. Natl. Acad. Sci. USA 97 (2000) 8021-8026
31. Yudkoff M., Daikhin Y., Nissim I., Jawad A., Wilson J., and Batshaw M. In vivo nitrogen metabolism in ornithine transcarbamylase deficiency. J. Clin. Invest. 98 (1996) 2167-2173
32. Brosnan J.T., Brosnan M.E., Yudkoff M., Nissim I., Daikhin Y., Lazarow A., Horyn O., and Nissim I. Alanine metabolism in the perfused rat liver. Studies with (15)N. J. Biol. Chem. 276 (2001) 31876-31882
33. Yang D., Hazey J.W., David F., Singh J., Rivchum R., Streem J.M., Halperin M.L., and Brunengraber H. Integrative physiology of splanchnic glutamine and ammonium metabolism. Am. J. Physiol. Endocrinol. Metab. 278 (2000) E469-E476
34. Felig P. The glucose-alanine cycle. Metabolism 22 (1973) 179-207
35. Schimke R.T. Differential effects of fasting and protein-free diets on levels of urea cycle enzymes in rat liver. J. Biol. Chem. 237 (1962) 1921-1924
36. Fowler B. Recent advances in the mechanism of pyridoxine-responsive disorders. J. Inherit. Metab. Dis. 8 Suppl 1 (1985) 76-83
37. Matalon R., Koch R., Michals-Matalon K., Moseley K., Surendran S., Tyring S., Erlandsen H., Gamez A., Stevens R.C., Romstad A., Moller L.B., and Guttler F. Biopterin responsive phenylalanine hydroxylase deficiency. Genet. Med. 6 (2004) 27-32
38. Tuchman M., Lee B., Lichter-Konecki U., Summar M.L., Yudkoff M., Cederbaum S.D., Kerr D.S., Diaz G.A., Seashore M.R., Lee H.S., McCarter R.J., Krischer J.P., and Batshaw M.L. Cross-sectional multicenter study of patients with urea cycle disorders in the United States. Mol. Genet. Metab. 94 (2008) 397-402
39. Brusilow S.W., and Maestri N.E. Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv. Pediatr. 43 (1996) 127-170
40. Nagata N., Matsuda I., and Oyanagi K. Estimated frequency of urea cycle enzymopathies in Japan. Am. J. Med. Genet. 39 (1991) 228-229
41. Natale P.J., and Tremblay G.C. Studies on the availability of intramitochondrial carbamoylphosphate for utilization in extramitochondrial reactions in rat liver. Arch. Biochem. Biophys. 162 (1974) 357-368
42. Alonso E., and Rubio V. Orotic aciduria due to arginine deprivation: changes in the levels of carbamoyl phosphate and of other urea cycle intermediates in mouse liver. J. Nutr. 119 (1989) 1188-1195